tiprankstipranks
Trending News
More News >
Cipla Ltd (IN:CIPLA)
:CIPLA
India Market
Advertisement

Cipla Ltd (CIPLA) Drug Pipeline

Compare
6 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Insulin Glargine, Insulin Lispro-Aabc
Diabetes Mellitus, Type 2
Phase IV
Active Not Recruiting
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Apr 15, 2024
Albuterol Sulfate Inhalation Aerosol (90 Mcg Per Actuation), Ventolin Hfa 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin Hfa, 90 Mcg/Inh Inhalation Aerosol_#2
Bronchial Asthma
Phase III
Completed
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Nov 23, 2023
Budesonide 80 Μg And Formoterol Fumarate Dihydrate 4.5 Μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol
Asthma
Phase III
Completed
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Mar 31, 2022
Fluticasone Propionate/Salmeterol 100/50 Μg, Advair Diskus 100/50 Dry Powder Inhaler, 60 Actuat
Bronchial Asthma
Phase III
Completed
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Dec 26, 2017
90 Mcg Reference Product, 180 Mcg Reference Product, 90 Mcg Test Product
Bronchial Asthma
Phase III
Completed
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
Dec 04, 2015

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Cipla Ltd (CIPLA) have in its pipeline
      CIPLA is currently developing the following drugs: Insulin Glargine, Insulin Lispro-Aabc, Albuterol Sulfate Inhalation Aerosol (90 Mcg Per Actuation), Ventolin Hfa 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin Hfa, 90 Mcg/Inh Inhalation Aerosol_#2, Budesonide 80 Μg And Formoterol Fumarate Dihydrate 4.5 Μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis